fluvax
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2006 (NCT00294788)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- fluvax
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02843321 | Phase 1 | Aug 1, 2012 | University of Sydney |
| NCT00294788 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2006 | Good Health Solutions, Probiomics Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Good Health Solutions | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Probiomics Ltd | For profit | 1 | 1 | 1 | 2006 |
| University of Sydney | Academic/Hospital | 1 | 1 | 1 | 2012 |
3 organizations
Page 1 / 1